| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
93,334 |
76,499 |
$4.59M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
66,372 |
58,647 |
$4.25M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
82,950 |
71,024 |
$4.06M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
26,136 |
20,665 |
$3.55M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
58,315 |
50,346 |
$3.14M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
63,673 |
18,979 |
$2.40M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
41,515 |
35,365 |
$2.02M |
| 80053 |
Comprehensive metabolic panel |
114,191 |
93,915 |
$2.01M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
21,913 |
20,005 |
$1.77M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
46,448 |
39,986 |
$1.72M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
46,436 |
39,979 |
$1.45M |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
13,736 |
12,724 |
$1.27M |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
36,311 |
31,312 |
$1.07M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
20,833 |
18,253 |
$904K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
20,814 |
16,017 |
$891K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
17,696 |
13,036 |
$858K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
11,601 |
10,841 |
$798K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
124,769 |
97,915 |
$773K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
8,475 |
7,101 |
$758K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
10,338 |
7,771 |
$741K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
14,847 |
11,355 |
$698K |
| 70450 |
Computed tomography, head or brain; without contrast material |
10,434 |
9,270 |
$670K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
38,177 |
30,609 |
$648K |
| 84702 |
|
17,339 |
12,670 |
$646K |
| 81001 |
|
52,157 |
44,866 |
$636K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13,963 |
12,657 |
$616K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
28,764 |
10,662 |
$569K |
| 59025 |
Fetal non-stress test |
8,371 |
2,669 |
$557K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
12,220 |
9,797 |
$554K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
7,713 |
6,920 |
$509K |
| 80061 |
Lipid panel |
43,172 |
39,275 |
$481K |
| G0378 |
Hospital observation service, per hour |
14,322 |
11,551 |
$477K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
66,763 |
46,237 |
$466K |
| 20610 |
|
7,202 |
5,711 |
$463K |
| 84443 |
Thyroid stimulating hormone (TSH) |
38,330 |
33,786 |
$460K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
17,681 |
14,608 |
$436K |
| 99215 |
Prolong outpt/office vis |
9,481 |
7,961 |
$429K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
18,453 |
16,603 |
$428K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
2,573 |
2,353 |
$425K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
48,087 |
43,418 |
$415K |
| 81025 |
|
37,679 |
32,815 |
$415K |
| 87081 |
|
18,318 |
16,972 |
$401K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
5,444 |
5,006 |
$398K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
4,055 |
3,659 |
$383K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
11,203 |
9,245 |
$377K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
24,042 |
22,427 |
$375K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
8,658 |
7,339 |
$375K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
44,278 |
35,435 |
$363K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
6,836 |
6,185 |
$331K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
16,001 |
13,941 |
$312K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
3,255 |
2,351 |
$302K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
6,261 |
5,621 |
$297K |
| 97161 |
|
7,290 |
6,640 |
$288K |
| 81420 |
Fetal chromosomal aneuploidy genomic sequence analysis panel |
760 |
577 |
$262K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
30,955 |
27,101 |
$252K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
4,658 |
4,176 |
$238K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
3,199 |
2,823 |
$228K |
| 82962 |
|
19,941 |
13,508 |
$226K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
6,491 |
5,488 |
$222K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
3,327 |
3,007 |
$219K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,643 |
1,371 |
$218K |
| 76830 |
Ultrasound, transvaginal |
5,214 |
4,832 |
$215K |
| 86481 |
|
3,138 |
2,834 |
$212K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
8,980 |
3,589 |
$211K |
| 87634 |
|
3,327 |
3,108 |
$204K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
5,239 |
748 |
$201K |
| 85027 |
|
37,167 |
31,255 |
$199K |
| 76801 |
|
5,031 |
4,315 |
$197K |
| 86780 |
|
20,864 |
18,343 |
$194K |
| 93798 |
|
3,324 |
577 |
$192K |
| 81003 |
|
30,836 |
27,167 |
$192K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
1,980 |
1,791 |
$187K |
| 84484 |
|
21,489 |
16,078 |
$185K |
| 90834 |
Psychotherapy, 45 minutes with patient |
4,240 |
2,460 |
$182K |
| 87210 |
|
12,760 |
11,127 |
$178K |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
1,094 |
1,002 |
$176K |
| 82728 |
|
10,923 |
9,710 |
$171K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
1,229 |
1,154 |
$171K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
3,822 |
3,559 |
$171K |
| 82607 |
|
13,914 |
12,315 |
$167K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
2,409 |
2,188 |
$159K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
3,620 |
1,840 |
$156K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
4,022 |
3,659 |
$155K |
| 12001 |
|
1,869 |
1,761 |
$154K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
6,028 |
5,712 |
$150K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
7,713 |
3,803 |
$148K |
| 80074 |
|
4,070 |
3,469 |
$147K |
| 87653 |
|
4,245 |
3,814 |
$144K |
| 82950 |
|
5,187 |
4,698 |
$136K |
| 95806 |
|
1,522 |
1,314 |
$132K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
7,761 |
5,825 |
$126K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
3,939 |
3,498 |
$125K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
766 |
717 |
$125K |
| 81511 |
|
930 |
869 |
$124K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
2,056 |
1,859 |
$124K |
| 71046 |
Radiologic examination, chest; 2 views |
21,453 |
19,312 |
$124K |
| 83690 |
|
20,846 |
17,808 |
$114K |
| 80050 |
General health panel |
9,740 |
5,119 |
$114K |
| 83880 |
|
5,453 |
4,694 |
$114K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
2,023 |
1,806 |
$114K |
| 97165 |
|
3,394 |
3,048 |
$112K |
| 86803 |
|
9,465 |
8,295 |
$112K |
| 99243 |
|
1,708 |
1,586 |
$111K |
| 84439 |
|
13,484 |
12,029 |
$110K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
1,438 |
1,310 |
$105K |
| 83655 |
|
8,634 |
7,393 |
$103K |
| 20553 |
|
1,872 |
1,752 |
$100K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,504 |
3,136 |
$97K |
| 86850 |
|
14,325 |
12,465 |
$96K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,846 |
1,629 |
$96K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
2,419 |
2,108 |
$96K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
2,206 |
1,953 |
$94K |
| 12011 |
|
1,087 |
1,012 |
$94K |
| 93971 |
|
2,988 |
2,715 |
$93K |
| 87340 |
|
10,033 |
8,816 |
$92K |
| 70496 |
|
1,474 |
1,309 |
$91K |
| 76642 |
|
2,348 |
2,061 |
$90K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
1,506 |
1,350 |
$89K |
| 87070 |
|
7,985 |
7,150 |
$89K |
| 86762 |
|
6,335 |
5,637 |
$89K |
| 80305 |
|
4,239 |
2,547 |
$86K |
| 93975 |
|
1,822 |
1,683 |
$84K |
| H0015 |
Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education |
1,222 |
140 |
$84K |
| 62323 |
|
653 |
599 |
$83K |
| 70498 |
|
1,503 |
1,327 |
$81K |
| 86480 |
|
1,313 |
1,215 |
$80K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,779 |
2,542 |
$76K |
| 85610 |
|
18,172 |
13,265 |
$70K |
| 90715 |
|
6,655 |
6,037 |
$69K |
| 93017 |
|
1,957 |
1,657 |
$69K |
| 87186 |
|
9,383 |
8,315 |
$67K |
| 84112 |
|
798 |
667 |
$67K |
| 82746 |
|
6,337 |
5,472 |
$66K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
5,200 |
4,914 |
$64K |
| 86703 |
|
3,667 |
3,193 |
$64K |
| 11981 |
|
515 |
470 |
$63K |
| 84153 |
|
3,474 |
3,159 |
$62K |
| 96367 |
|
1,292 |
934 |
$62K |
| 80143 |
|
3,439 |
2,837 |
$61K |
| 83735 |
|
13,772 |
10,500 |
$60K |
| 76536 |
|
1,468 |
1,347 |
$60K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
1,732 |
1,431 |
$60K |
| 72141 |
|
975 |
862 |
$59K |
| 82043 |
|
9,762 |
8,903 |
$57K |
| 87077 |
|
6,362 |
5,649 |
$56K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
4,608 |
3,711 |
$56K |
| 80076 |
|
4,864 |
4,246 |
$54K |
| 76770 |
|
1,078 |
990 |
$53K |
| 87147 |
|
8,205 |
6,546 |
$53K |
| 83605 |
|
6,671 |
5,646 |
$53K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
284 |
266 |
$52K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
44,594 |
37,370 |
$49K |
| 52000 |
|
209 |
188 |
$47K |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
314 |
282 |
$47K |
| 74018 |
|
5,014 |
4,499 |
$46K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
377 |
356 |
$46K |
| 83550 |
|
6,760 |
6,046 |
$46K |
| 71250 |
|
1,648 |
1,513 |
$45K |
| 84703 |
|
5,395 |
4,841 |
$45K |
| 82565 |
|
3,409 |
2,906 |
$44K |
| 58300 |
|
681 |
627 |
$43K |
| 12002 |
|
501 |
479 |
$42K |
| 87505 |
|
390 |
361 |
$42K |
| 85379 |
|
5,434 |
4,856 |
$42K |
| T1016 |
Case management, each 15 minutes |
2,274 |
1,572 |
$42K |
| 90686 |
|
6,079 |
5,421 |
$41K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,373 |
2,180 |
$41K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
1,305 |
1,218 |
$41K |
| 83540 |
|
7,423 |
6,629 |
$40K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
33,101 |
26,009 |
$40K |
| 84146 |
|
2,097 |
1,730 |
$40K |
| 95811 |
|
232 |
217 |
$40K |
| 83001 |
|
2,078 |
1,721 |
$38K |
| 10060 |
|
479 |
440 |
$38K |
| 97162 |
|
1,185 |
1,096 |
$38K |
| 73110 |
|
4,795 |
3,865 |
$38K |
| 73130 |
|
5,710 |
4,684 |
$37K |
| 80179 |
|
3,403 |
2,813 |
$37K |
| 70486 |
|
1,148 |
1,052 |
$37K |
| 73610 |
|
6,252 |
5,331 |
$37K |
| 87641 |
|
989 |
865 |
$36K |
| 73630 |
|
7,351 |
6,119 |
$36K |
| 86900 |
|
10,925 |
9,317 |
$35K |
| 83970 |
|
1,262 |
1,144 |
$35K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
8,623 |
7,738 |
$35K |
| 97803 |
|
2,056 |
1,604 |
$34K |
| 97116 |
|
2,362 |
1,268 |
$34K |
| 82570 |
|
7,396 |
6,562 |
$34K |
| 95886 |
|
1,117 |
1,025 |
$33K |
| 86901 |
|
11,677 |
9,879 |
$33K |
| 87040 |
|
2,916 |
2,524 |
$33K |
| 93970 |
|
841 |
772 |
$33K |
| 88738 |
|
2,060 |
1,903 |
$32K |
| 86706 |
|
3,424 |
3,023 |
$32K |
| 76942 |
|
3,269 |
2,900 |
$31K |
| 94060 |
|
1,647 |
1,489 |
$30K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
65 |
53 |
$29K |
| 83020 |
|
2,443 |
2,152 |
$29K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
732 |
683 |
$29K |
| 77066 |
Tomosynthesis, mammo |
1,173 |
1,098 |
$29K |
| 73560 |
|
5,062 |
4,072 |
$29K |
| 85730 |
|
6,691 |
5,783 |
$28K |
| 97802 |
|
1,408 |
1,219 |
$28K |
| 83516 |
|
1,443 |
1,189 |
$28K |
| 87522 |
Neg quan hep c or qual rna |
672 |
567 |
$26K |
| 86140 |
|
5,894 |
4,939 |
$26K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
137 |
124 |
$26K |
| 11982 |
|
254 |
226 |
$25K |
| 84403 |
|
1,156 |
1,008 |
$25K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
29 |
29 |
$25K |
| 94729 |
|
2,488 |
2,291 |
$25K |
| J9271 |
Injection, pembrolizumab, 1 mg |
20 |
12 |
$25K |
| 73140 |
|
2,955 |
2,572 |
$25K |
| 86235 |
|
566 |
309 |
$24K |
| 82784 |
|
1,970 |
1,683 |
$23K |
| H2012 |
Behavioral health day treatment, per hour |
1,366 |
51 |
$23K |
| G0008 |
Administration of influenza virus vaccine |
9,774 |
8,721 |
$23K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
94 |
81 |
$23K |
| 73221 |
|
351 |
326 |
$23K |
| 82550 |
|
3,937 |
3,275 |
$22K |
| 86038 |
|
2,212 |
1,887 |
$21K |
| 73030 |
|
5,546 |
4,840 |
$21K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
382 |
350 |
$21K |
| 85007 |
|
8,178 |
6,345 |
$21K |
| 72100 |
|
3,365 |
3,085 |
$20K |
| 87075 |
|
2,622 |
2,196 |
$20K |
| 92567 |
|
866 |
813 |
$20K |
| 82105 |
|
682 |
561 |
$20K |
| 87529 |
|
425 |
384 |
$19K |
| 84481 |
|
1,544 |
1,356 |
$19K |
| 87088 |
|
2,659 |
2,424 |
$19K |
| 92557 |
|
408 |
391 |
$18K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
109 |
89 |
$18K |
| 90670 |
|
1,538 |
1,364 |
$18K |
| H1004 |
Prenatal care, at-risk enhanced service; follow-up home visit |
630 |
487 |
$18K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
195 |
178 |
$17K |
| 85652 |
|
7,085 |
6,217 |
$17K |
| 86704 |
|
1,811 |
1,594 |
$17K |
| 84550 |
|
3,743 |
3,062 |
$16K |
| 36902 |
|
29 |
27 |
$16K |
| 73564 |
|
3,029 |
2,773 |
$16K |
| 77080 |
|
590 |
545 |
$16K |
| 87205 |
|
3,897 |
3,303 |
$15K |
| 73590 |
|
1,993 |
1,679 |
$14K |
| 0042T |
|
362 |
330 |
$14K |
| 76870 |
|
241 |
217 |
$14K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
745 |
354 |
$14K |
| 99406 |
|
3,449 |
2,834 |
$14K |
| 94726 |
|
2,412 |
2,226 |
$14K |
| 99205 |
Prolong outpt/office vis |
391 |
354 |
$13K |
| 84132 |
|
2,192 |
1,468 |
$13K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
351 |
275 |
$13K |
| 73502 |
|
2,903 |
2,649 |
$13K |
| 70491 |
|
219 |
202 |
$13K |
| 71045 |
Radiologic examination, chest; single view |
26,255 |
22,670 |
$13K |
| 29848 |
|
28 |
26 |
$12K |
| 84156 |
|
2,006 |
1,614 |
$12K |
| 71271 |
|
348 |
312 |
$12K |
| 64483 |
|
87 |
78 |
$12K |
| 0002A |
|
966 |
732 |
$12K |
| 93296 |
|
632 |
554 |
$12K |
| H1003 |
Prenatal care, at-risk enhanced service; education |
599 |
461 |
$12K |
| 90674 |
|
1,185 |
1,069 |
$12K |
| 99385 |
|
404 |
341 |
$11K |
| 93351 |
|
88 |
84 |
$11K |
| 73090 |
|
1,418 |
1,184 |
$11K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
9,330 |
8,202 |
$11K |
| 0001A |
|
990 |
752 |
$11K |
| 96415 |
|
136 |
78 |
$11K |
| 90651 |
|
502 |
447 |
$11K |
| 82670 |
|
385 |
312 |
$11K |
| 82077 |
|
936 |
778 |
$11K |
| 36430 |
|
92 |
67 |
$11K |
| 77065 |
Tomosynthesis, mammo |
678 |
578 |
$11K |
| 82800 |
|
1,404 |
1,135 |
$11K |
| 76820 |
|
916 |
487 |
$10K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
127 |
112 |
$10K |
| 95816 |
|
109 |
100 |
$10K |
| 73080 |
|
1,839 |
1,646 |
$10K |
| 80164 |
|
630 |
549 |
$9K |
| 72114 |
|
459 |
429 |
$9K |
| 86431 |
|
1,772 |
1,498 |
$9K |
| 72052 |
|
309 |
288 |
$9K |
| 91320 |
|
427 |
365 |
$9K |
| 85049 |
|
1,335 |
997 |
$9K |
| 77062 |
|
702 |
664 |
$9K |
| 72110 |
|
1,281 |
1,153 |
$9K |
| 82010 |
|
1,440 |
1,215 |
$9K |
| 83615 |
|
1,845 |
1,540 |
$9K |
| 99397 |
|
411 |
391 |
$8K |
| 29125 |
|
234 |
203 |
$8K |
| 58100 |
|
73 |
68 |
$8K |
| 72040 |
|
996 |
927 |
$8K |
| 86580 |
|
542 |
501 |
$7K |
| 82075 |
|
689 |
279 |
$7K |
| 85014 |
|
2,263 |
1,818 |
$7K |
| 82150 |
|
1,335 |
1,174 |
$7K |
| 82951 |
|
172 |
149 |
$7K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
40 |
38 |
$7K |
| 82140 |
|
632 |
482 |
$7K |
| 36000 |
|
449 |
331 |
$6K |
| 72170 |
|
917 |
780 |
$6K |
| 80177 |
|
532 |
455 |
$6K |
| 86160 |
|
327 |
240 |
$6K |
| 83520 |
|
406 |
336 |
$6K |
| 43248 |
|
46 |
41 |
$6K |
| 82465 |
|
1,428 |
1,332 |
$6K |
| 29581 |
|
213 |
93 |
$6K |
| 84100 |
|
1,847 |
1,481 |
$6K |
| 84460 |
|
1,167 |
1,058 |
$6K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
4,162 |
3,621 |
$6K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
221 |
207 |
$5K |
| 51798 |
|
2,188 |
1,833 |
$5K |
| 87252 |
|
147 |
138 |
$5K |
| J0897 |
Injection, denosumab, 1 mg |
86 |
64 |
$5K |
| 97163 |
|
195 |
188 |
$5K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
74 |
55 |
$5K |
| 90716 |
|
227 |
196 |
$5K |
| 82553 |
|
1,030 |
868 |
$5K |
| 86308 |
|
482 |
437 |
$5K |
| 58301 |
|
90 |
82 |
$5K |
| 99245 |
|
77 |
68 |
$5K |
| 84165 |
|
633 |
543 |
$5K |
| G0424 |
Pulmonary rehabilitation, including exercise (includes monitoring), one hour, per session, up to two sessions per day |
87 |
24 |
$5K |
| 83002 |
|
307 |
251 |
$5K |
| 73565 |
|
2,920 |
2,563 |
$5K |
| 86787 |
|
622 |
567 |
$5K |
| 87449 |
|
480 |
439 |
$5K |
| 77061 |
|
353 |
309 |
$5K |
| 73562 |
|
1,786 |
1,557 |
$5K |
| 90656 |
|
617 |
574 |
$5K |
| 84450 |
|
890 |
818 |
$5K |
| 86039 |
|
562 |
431 |
$5K |
| 82803 |
|
256 |
218 |
$4K |
| 82947 |
|
813 |
720 |
$4K |
| 95819 |
|
66 |
61 |
$4K |
| 86225 |
|
396 |
305 |
$4K |
| 86696 |
|
257 |
206 |
$4K |
| 85018 |
|
1,708 |
1,374 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
91,869 |
71,052 |
$4K |
| 57454 |
|
35 |
25 |
$4K |
| Q3014 |
Telehealth originating site facility fee |
1,644 |
1,355 |
$4K |
| 93976 |
|
97 |
92 |
$4K |
| 95909 |
|
102 |
96 |
$4K |
| 71101 |
|
1,459 |
1,323 |
$4K |
| 85046 |
|
679 |
571 |
$4K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
90 |
82 |
$4K |
| 78580 |
|
18 |
14 |
$4K |
| 86364 |
|
452 |
399 |
$3K |
| 84480 |
|
272 |
256 |
$3K |
| 88307 |
|
476 |
410 |
$3K |
| 73552 |
|
686 |
602 |
$3K |
| 11983 |
|
31 |
25 |
$3K |
| 86923 |
|
97 |
77 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
24,971 |
19,076 |
$3K |
| 36591 |
|
2,269 |
1,096 |
$3K |
| 78830 |
|
19 |
15 |
$3K |
| 86200 |
|
287 |
251 |
$3K |
| 95874 |
|
53 |
51 |
$3K |
| 94070 |
|
67 |
65 |
$3K |
| 86695 |
|
241 |
192 |
$3K |
| 96368 |
|
109 |
67 |
$3K |
| 87563 |
|
122 |
109 |
$3K |
| 95910 |
|
129 |
116 |
$3K |
| 95813 |
|
26 |
24 |
$3K |
| 77336 |
|
85 |
25 |
$3K |
| 77091 |
|
349 |
308 |
$3K |
| 74178 |
|
41 |
35 |
$3K |
| 76813 |
|
120 |
67 |
$3K |
| 20550 |
|
32 |
28 |
$3K |
| 90480 |
|
258 |
220 |
$2K |
| 93225 |
|
82 |
78 |
$2K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
16 |
12 |
$2K |
| 19083 |
|
13 |
12 |
$2K |
| 86255 |
|
209 |
188 |
$2K |
| 64450 |
|
67 |
55 |
$2K |
| 74183 |
|
31 |
29 |
$2K |
| 90677 |
|
656 |
513 |
$2K |
| 94150 |
|
4,647 |
3,679 |
$2K |
| 84145 |
|
148 |
129 |
$2K |
| 82627 |
|
101 |
80 |
$2K |
| 29515 |
|
17 |
16 |
$2K |
| 87109 |
|
157 |
135 |
$2K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
1,174 |
1,003 |
$2K |
| 10061 |
|
14 |
12 |
$2K |
| 31575 |
|
16 |
12 |
$2K |
| 80175 |
|
87 |
78 |
$2K |
| 97035 |
|
127 |
65 |
$2K |
| 90837 |
Psychotherapy, 53 minutes with patient |
36 |
24 |
$2K |
| G0009 |
Administration of pneumococcal vaccine |
3,672 |
3,207 |
$2K |
| 82533 |
|
129 |
80 |
$2K |
| 72070 |
|
429 |
392 |
$2K |
| 90662 |
|
1,157 |
1,023 |
$2K |
| 90380 |
|
14 |
12 |
$2K |
| 87536 |
|
16 |
12 |
$2K |
| 87324 |
|
88 |
86 |
$2K |
| 90633 |
|
606 |
531 |
$2K |
| 86258 |
|
129 |
112 |
$2K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
421 |
367 |
$1K |
| 90791 |
Psychiatric diagnostic evaluation |
154 |
90 |
$1K |
| 87110 |
|
87 |
78 |
$1K |
| 93298 |
|
104 |
99 |
$1K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
19 |
18 |
$1K |
| 64493 |
|
21 |
13 |
$1K |
| 83037 |
|
296 |
275 |
$1K |
| 88304 |
|
1,340 |
1,214 |
$1K |
| 99386 |
|
49 |
39 |
$1K |
| 82248 |
|
299 |
216 |
$1K |
| 86376 |
|
71 |
63 |
$1K |
| 72156 |
|
13 |
12 |
$1K |
| 94375 |
|
155 |
147 |
$1K |
| 96417 |
|
32 |
13 |
$1K |
| H1002 |
Prenatal care, at risk enhanced service; care coordination |
34 |
26 |
$1K |
| 80047 |
|
12 |
12 |
$1K |
| 74019 |
|
755 |
702 |
$1K |
| 64415 |
|
15 |
12 |
$1K |
| 86618 |
|
60 |
53 |
$983.22 |
| 93226 |
|
83 |
79 |
$978.80 |
| 93321 |
|
15 |
12 |
$964.32 |
| 90734 |
|
177 |
170 |
$955.76 |
| 90732 |
|
464 |
418 |
$944.84 |
| 91300 |
|
257 |
163 |
$920.93 |
| 96150 |
|
28 |
26 |
$902.19 |
| G0109 |
Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes |
45 |
38 |
$883.23 |
| 73070 |
|
76 |
58 |
$872.50 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
145 |
133 |
$840.14 |
| 93242 |
|
127 |
104 |
$823.75 |
| 88142 |
|
56 |
39 |
$817.74 |
| 86593 |
|
131 |
108 |
$799.86 |
| 82378 |
|
98 |
86 |
$799.40 |
| 83721 |
|
155 |
136 |
$784.14 |
| 86334 |
|
59 |
51 |
$752.18 |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
23 |
14 |
$736.91 |
| 99496 |
|
61 |
55 |
$732.21 |
| 76937 |
|
355 |
314 |
$720.12 |
| 80178 |
|
133 |
118 |
$719.53 |
| 97150 |
Therapeutic procedure(s), group (2 or more individuals) |
176 |
104 |
$710.44 |
| 86800 |
|
37 |
28 |
$705.89 |
| 96160 |
|
433 |
402 |
$679.66 |
| 93922 |
|
61 |
51 |
$678.82 |
| 0124A |
|
46 |
44 |
$674.32 |
| 0004A |
|
109 |
99 |
$662.68 |
| 86141 |
|
57 |
51 |
$659.82 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
13,159 |
12,516 |
$637.45 |
| 90384 |
|
14 |
13 |
$622.65 |
| 73060 |
|
164 |
142 |
$621.86 |
| 84155 |
|
93 |
85 |
$599.90 |
| 73600 |
|
93 |
82 |
$562.56 |
| 85045 |
|
204 |
163 |
$558.81 |
| 84402 |
|
26 |
24 |
$549.85 |
| 90746 |
|
125 |
111 |
$546.18 |
| J7323 |
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose |
16 |
12 |
$545.32 |
| 92587 |
|
13 |
12 |
$545.16 |
| 73700 |
|
14 |
14 |
$506.47 |
| 73620 |
|
31 |
25 |
$505.17 |
| 90707 |
|
111 |
96 |
$476.41 |
| 72050 |
|
84 |
70 |
$476.23 |
| 93299 |
|
27 |
26 |
$471.69 |
| 89051 |
|
28 |
24 |
$461.20 |
| 90714 |
|
104 |
89 |
$458.66 |
| 84704 |
|
32 |
24 |
$454.61 |
| 84163 |
|
32 |
24 |
$454.00 |
| 83525 |
|
45 |
41 |
$448.59 |
| 93880 |
|
13 |
12 |
$442.81 |
| 90713 |
|
192 |
120 |
$423.67 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
1,656 |
1,386 |
$422.81 |
| 87140 |
|
88 |
79 |
$421.76 |
| 90632 |
|
85 |
68 |
$417.10 |
| 77090 |
|
69 |
60 |
$412.77 |
| 90678 |
|
62 |
58 |
$407.06 |
| 88342 |
|
1,346 |
1,162 |
$382.63 |
| 99292 |
|
990 |
876 |
$379.37 |
| 51702 |
|
16 |
13 |
$372.81 |
| 90710 |
|
74 |
49 |
$370.14 |
| 82952 |
|
94 |
84 |
$369.24 |
| G0010 |
Administration of hepatitis b vaccine |
569 |
496 |
$362.93 |
| 90681 |
|
162 |
156 |
$362.32 |
| 69210 |
|
42 |
38 |
$361.69 |
| 96402 |
|
33 |
24 |
$346.94 |
| 87209 |
|
16 |
13 |
$329.36 |
| 90750 |
|
67 |
52 |
$323.85 |
| 86694 |
|
30 |
26 |
$311.61 |
| 96376 |
|
5,527 |
4,068 |
$310.81 |
| 83718 |
|
43 |
43 |
$285.65 |
| 94760 |
|
1,459 |
1,120 |
$280.30 |
| 82977 |
|
57 |
51 |
$279.63 |
| 82805 |
|
18 |
13 |
$279.37 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
805 |
703 |
$275.12 |
| 84270 |
|
14 |
12 |
$268.68 |
| 73660 |
|
68 |
66 |
$266.43 |
| G0136 |
Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months |
121 |
115 |
$253.76 |
| 90723 |
|
184 |
173 |
$248.30 |
| 70360 |
|
42 |
38 |
$236.15 |
| J2790 |
Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) |
12 |
12 |
$227.63 |
| 84436 |
|
25 |
25 |
$217.57 |
| 99407 |
|
254 |
217 |
$213.98 |
| 90698 |
|
174 |
166 |
$210.61 |
| 82247 |
|
59 |
39 |
$203.11 |
| 87329 |
|
12 |
12 |
$200.75 |
| 86870 |
|
109 |
90 |
$200.72 |
| 90687 |
|
28 |
27 |
$196.75 |
| J3490 |
Unclassified drugs |
694 |
576 |
$188.00 |
| 93325 |
|
16 |
13 |
$186.85 |
| 73000 |
|
68 |
50 |
$180.30 |
| 87338 |
|
15 |
14 |
$179.21 |
| 72220 |
|
29 |
26 |
$176.12 |
| 80171 |
|
18 |
14 |
$173.76 |
| 87177 |
|
16 |
13 |
$170.07 |
| 96153 |
|
343 |
130 |
$159.32 |
| 94762 |
|
45 |
41 |
$149.05 |
| 86765 |
|
14 |
13 |
$148.58 |
| 90739 |
|
21 |
20 |
$112.92 |
| 88112 |
|
31 |
24 |
$109.10 |
| 51701 |
|
61 |
57 |
$97.71 |
| 87206 |
|
13 |
12 |
$89.20 |
| G0296 |
Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) |
17 |
16 |
$85.24 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
3,549 |
3,185 |
$84.53 |
| L3808 |
Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment |
26 |
25 |
$83.31 |
| 73100 |
|
13 |
12 |
$82.49 |
| 94010 |
|
313 |
284 |
$81.90 |
| 82575 |
|
14 |
12 |
$80.03 |
| 0071A |
|
17 |
14 |
$77.08 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
699 |
646 |
$74.54 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
23,058 |
17,866 |
$74.12 |
| 91307 |
|
63 |
57 |
$72.80 |
| 93270 |
|
14 |
12 |
$68.76 |
| L1270 |
Addition to tlso, (low profile), abdominal pad |
33 |
13 |
$63.83 |
| 90474 |
|
386 |
359 |
$62.51 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12,254 |
9,945 |
$58.96 |
| 72072 |
|
13 |
12 |
$50.60 |
| 87185 |
|
14 |
13 |
$48.94 |
| 73523 |
|
14 |
12 |
$47.12 |
| 80069 |
|
13 |
13 |
$47.08 |
| 36416 |
|
216 |
166 |
$44.63 |
| 82330 |
|
15 |
13 |
$41.96 |
| G8984 |
Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals |
79 |
67 |
$38.40 |
| 0072A |
|
20 |
19 |
$38.16 |
| 90744 |
|
13 |
12 |
$36.84 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
5,822 |
4,273 |
$29.42 |
| J1953 |
Injection, levetiracetam, 10 mg |
353 |
286 |
$24.83 |
| 99152 |
|
1,782 |
1,583 |
$22.65 |
| C1769 |
Guide wire |
2,794 |
2,074 |
$19.85 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,860 |
1,371 |
$19.02 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
8,378 |
6,907 |
$15.12 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
189 |
175 |
$12.60 |
| 99153 |
Mod sedat endo service >5yrs |
1,107 |
988 |
$11.33 |
| J2704 |
Injection, propofol, 10 mg |
15,175 |
11,253 |
$9.97 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
7,277 |
5,714 |
$8.29 |
| 90696 |
|
13 |
13 |
$7.99 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
2,774 |
2,440 |
$6.31 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
3,451 |
2,519 |
$4.40 |
| G0433 |
Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening |
14 |
12 |
$3.66 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
21,193 |
17,647 |
$2.23 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
6,070 |
4,599 |
$1.89 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,779 |
1,372 |
$1.34 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
7,389 |
5,504 |
$0.90 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
11,868 |
10,132 |
$0.44 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
5,774 |
4,944 |
$0.41 |
| J1630 |
Injection, haloperidol, up to 5 mg |
1,115 |
870 |
$0.27 |
| J1644 |
Injection, heparin sodium, per 1000 units |
2,716 |
1,251 |
$0.14 |
| J2060 |
Injection, lorazepam, 2 mg |
2,638 |
2,142 |
$0.08 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
2,521 |
1,998 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
3,205 |
1,416 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
267 |
218 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
701 |
560 |
$0.00 |
| J1756 |
Injection, iron sucrose, 1 mg |
1,159 |
409 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
172 |
133 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,319 |
3,432 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
504 |
444 |
$0.00 |
| J1729 |
Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg |
266 |
94 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
102 |
77 |
$0.00 |
| J3260 |
Injection, tobramycin sulfate, up to 80 mg |
56 |
40 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
86 |
68 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
106 |
92 |
$0.00 |
| L3040 |
Foot, arch support, removable, premolded, longitudinal, each |
14 |
13 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
593 |
486 |
$0.00 |
| A4550 |
Surgical trays |
43 |
43 |
$0.00 |
| G8985 |
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
175 |
141 |
$0.00 |
| C1758 |
Catheter, ureteral |
17 |
12 |
$0.00 |
| A6219 |
Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing |
87 |
50 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
45 |
38 |
$0.00 |
| 91312 |
|
19 |
19 |
$0.00 |
| C1780 |
Lens, intraocular (new technology) |
32 |
25 |
$0.00 |
| 69209 |
|
14 |
12 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
13 |
12 |
$0.00 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
53 |
50 |
$0.00 |
| 31720 |
|
61 |
59 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
20 |
12 |
$0.00 |
| J0694 |
Injection, cefoxitin sodium, 1 gm |
21 |
14 |
$0.00 |
| 95913 |
|
16 |
13 |
$0.00 |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
965 |
810 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
417 |
342 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
115 |
96 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
1,249 |
1,064 |
$0.00 |
| J1726 |
Injection, hydroxyprogesterone caproate, (makena), 10 mg |
265 |
92 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
734 |
584 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
380 |
301 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
2,200 |
1,820 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
246 |
223 |
$0.00 |
| J3411 |
Injection, thiamine hcl, 100 mg |
114 |
93 |
$0.00 |
| J3360 |
Injection, diazepam, up to 5 mg |
247 |
213 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
263 |
242 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
1,519 |
971 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
1,159 |
1,108 |
$0.00 |
| A9270 |
Non-covered item or service |
14,009 |
10,533 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
814 |
665 |
$0.00 |
| C9399 |
Unclassified drugs or biologicals |
138 |
126 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
748 |
498 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
201 |
179 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
24 |
14 |
$0.00 |
| 88300 |
|
116 |
106 |
$0.00 |
| 3008F |
|
232 |
220 |
$0.00 |
| V2632 |
Posterior chamber intraocular lens |
67 |
55 |
$0.00 |
| 95911 |
|
26 |
25 |
$0.00 |
| 88341 |
|
46 |
38 |
$0.00 |
| C1781 |
Mesh (implantable) |
16 |
12 |
$0.00 |
| A9540 |
Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries |
19 |
15 |
$0.00 |
| J7674 |
Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg |
52 |
39 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
18 |
12 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
78 |
71 |
$0.00 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
47 |
40 |
$0.00 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
14 |
13 |
$0.00 |